Form 4: Medtronic Executive Reports Stock Transactions

Denise L. Blomquist, Chief Accounting Officer at Medtronic plc, reported transactions involving ordinary shares and restricted stock units.

Summary

• Denise L. Blomquist, Chief Accounting Officer of Medtronic plc, reported the acquisition of 1,508 ordinary shares on April 27, 2026, valued at $0.
• On April 28, 2026, 318 ordinary shares were disposed of, with a transaction price of $81.9 per share, resulting in 13,262 ordinary shares beneficially owned.
• The acquisition of 1,508 shares represents restricted stock units that vest over three years.
• The disposal of 318 shares was for tax payments upon the vesting of previously reported restricted stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it details routine insider stock transactions for compensation and tax purposes without indicating significant changes in beneficial ownership or strategic shifts.

Positives

• Reporting person acquired 1,508 restricted stock units, indicating continued equity incentive.
• 106 additional shares were acquired through dividend reinvestment, showing growth in holdings.

Negatives

• 318 shares were disposed of to cover tax obligations, reducing the direct shareholding.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into executive stock activity within the medical device industry.

Stakeholder Impact

• Shareholders: Increased transparency into executive compensation and stock holdings.
• Employees: Indirectly reflects the company's equity incentive programs.

Key Dates

Keywords

Medtronic plc, MDT, Form 4, Stock Transaction, Beneficial Ownership, Restricted Stock Units, Chief Accounting Officer, SEC Filing